Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Americans Go Abroad, Online for New Diet Pill

Hung up in FDA approval process, pill's already scoring big

By Dustin Lushing, Newser Staff

Posted Jun 11, 2007 8:21 PM CDT

(Newser) – The weight loss drug Acomplia is stuck in FDA limbo, but that isn't stopping Americans from ordering it off the Internet or buying it in Europe, where it's legal. If the government rules that its lowering of weight and cholesterol balances out the possible side... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

There are no comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

Cops Shoot Naked Guy Eating Man's Face on Highway

Japanese Artist Serves Up Own Cooked Genitals

Bloomberg (Source Grid »)

More on the increased incidence of suicidal thoughts or actions
Reuters

medicine • suicide • FDA • depression • obesity epidemic • Sanofi Aventis • Acomplia • weight loss • diet pills • cholesterol

More Newser Stories

FDA Advisory Panel Rejects Weight-Loss Drug

Possible side effects send Acomplia to the sidelines

(NEWSER) - Accomplia, a weight-loss drug marketed in 18 other countries, failed to win approval from an FDA advisory board yesterday. The 14-member panel of outside experts ruled unanimously that manufacturer Sanofi-Aventis had not dispelled concerns about the safety of the drug, whose potential side effects include suicidal thoughts, anxiety, and depression. More»

Feds Back Weight-Loss Pill Qnexa

Step toward first FDA-approved diet drug in years

(NEWSER) - A federal panel's decision has brought us a step closer to the first FDA-approved prescription weight-loss drug in more than 10 years. Qnexa was earlier rejected by the FDA over possible safety risks, but the non-FDA panel found, by a vote of 20-2, that the drug's benefits outweigh such risks, the Wall Street Journal reports. The decision effectively urges FDA approval for sale; the agency will decide by April 17. More»

LASIK Patients Urge Better Oversight

Eye surgery can have serious side-effects, they tell FDA

(NEWSER) - Patients experiencing painful and sometimes debilitating side-effects of LASIK eye surgery urged regulators today to keep a closer watch on the procedure, Reuters reports. A surgeon speaking to an FDA panel—soliticing advice for possible warnings after receiving 140 complaints—did not discount the allegations but said “the great majority of our patients see as well or better” after the procedure. More»

FDA Mandates Suicide Risk Assessment in Drug Trials

Danger doesn't lie only in antidepressants

(NEWSER) - The Food and Drug Administration is now requiring drug companies to monitor suicide warning signs in clinical trials for experimental drugs, the New York Times reports. In the wake of studies showing that antidepressants might increase the risk of self-harm in children and teens, the agency is showing an awareness that a surprising variety of drugs can have psychiatric effects. More»

Antidepressant Warning Preceded Youth Suicide Surge

Unintended effect unfolded as use fell

(NEWSER) - Four years after the FDA and other agencies sparked a drop in antidepressant use by labeling the meds a suicide risk for young people, a new study shows the results were exactly the opposite of what regulators intended. From 2003 to 2004, the suicide rate among people under 19 rose 14%, an unprecedented spike, the Washington Post reports. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

Americans Go Abroad, Online for New Diet Pill

Hung up in FDA approval process, pill's already scoring big

medicine • suicide • FDA • depression • obesity epidemic • Sanofi Aventis • Acomplia • weight loss • diet pills • cholesterol

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

FDA Advisory Panel Rejects Weight-Loss Drug

Possible side effects send Acomplia to the sidelines

Feds Back Weight-Loss Pill Qnexa

Step toward first FDA-approved diet drug in years

LASIK Patients Urge Better Oversight

Eye surgery can have serious side-effects, they tell FDA

FDA Mandates Suicide Risk Assessment in Drug Trials

Danger doesn't lie only in antidepressants

Antidepressant Warning Preceded Youth Suicide Surge

Unintended effect unfolded as use fell

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?